Accelerating Cell Line Development with Integrated Automation

Biologics and cell therapy programs face increasing pressure to generate high-quality cell lines and physiologically relevant 3D models, faster and with greater reproducibility.

Integrated automation is emerging as a powerful solution, connecting single-cell isolation, clone tracking, productivity screening, and organoid selection into unified workflows.

In this article, explore how these technologies are helping teams accelerate decision-making, improve monoclonality assurance, and scale complex biology workflows.

What You'll Learn:

• Why modern CLD workflows demand higher throughput and stronger monoclonality assurance

• How next-generation nanowell plates improve single-cell isolation and clone detection

• How fluorescence-based screening enables productivity assessment in just 3–4 days

• Real data comparing standard vs. next generation nanowell formats

• How automation supports reproducible organoid and spheroid workflows

• Why integrated, data-connected systems reduce variability and accelerate development timelines